CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | +20.0% | 1,394 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | 0.0% | 1,394 | -6.6% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 1,493 | -1.3% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 1,512 | +1.4% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 1,491 | -1.4% | 0.00% | – |
Q1 2021 | $8,000 | -38.5% | 1,512 | +51.2% | 0.00% | – |
Q4 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +233.3% | 1,000 | +400.0% | 0.00% | – |
Q4 2018 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |